GEN Magazine

Volume 40, Issue No. 09, September 2020

Browse the print magazine as a flipbook

Browse the print magazine supplement as a flipbook

Website Content from This Issue

Cold Cases Heat Up with New Forensic DNA Methods

Othram Wall

CRISPR Value Chains Support New Therapeutic Strategies

CRISPR-Cas9 gene editing complex, illustration

Nonviral CRISPR Delivery Vehicles Lay the Smart Siege

ultrasound-controlled nanomaterials

Multimodal Screening—The Future of Drug Discovery and Development

Drug Targets Identified More Discerningly

Huntington’s disease

Genetic Engineering, No Virus Required

CAR T-Cell Optimization Starts in Production, Extends to Therapy

cancer cell

Nanopore Sequencing Looks to the Long Haul

Oxford Nanopore Technologies lab

Catch RNA Splicing Errors to Envision Novel Correctives

Self-splicing RNA intron, molecular model

Real-Time Potency Assay for CAR T-Cell Killing of Cancer Cells

CAR T cell immunotherapy, illustration

Bioequivalence, Bioassays, and Biowaivers: How Integrated Testing Can Accelerate Generic Drug Development

Female scientist examining bottle in research lab

Data Robustness and Reproducibility in Gene Editing Applications: Today’s Limits and Tomorrow’s Potential

BioP DNA and Cells header image 210x150mm

Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need

Chris Coffin of Ionis Pharmaceuticals

The Future of Genomic Medicine

Genuity Science Lab

Rapid Target Discovery in Microbes Enabled by Onyx™ Platform

Flow Imaging Microscopy

Auxiliary Air Fume Hoods

UV-Visible-NIR Polarization Spectroscopy of Microscopic Samples

SARS-CoV-2 Kit

Preclinical Research Toolbox

WHO: International Clinical Trials Registry Platform

Roach Lab

Abcam Essential Antibody Guides

Gene Therapy: It’s Time to Talk about High-Dose AAV

DNA SciFi Helix